Visalakshi Chandramouli is the founding partner of Tata Capital Healthcare Fund. She has two decades of experience in healthcare private equity, equity research and pharmaceutical R & D operations. Visalakshi presently heads and drives the fund raising and investment management activities of Tata Capital Healthcare Fund. Visalakshi started her career as a research scientist at Cipla, a global pharmaceutical company, and thereafter spent over 12 years as the lead healthcare investment analyst at two leading financial services firms, Kotak Securities and Merrill Lynch. Prior to joining Tata Capital in 2008, Visalakshi was senior director of India healthcare equity research at Merrill Lynch (India).
Visalakshi brings on board a deep experience of technical skills within the pharmaceutical industry as well as commercial and investment experience in the industry. In her previous two roles at DSP Merrill Lynch and Kotak Securities, she was involved in executing IPO/American Depository Shares ("ADS") transactions aggregating to value of c.USD 400 million for Indian pharmaceutical companies for close to a decade. In her present role, apart from sourcing and execution of private equity transactions for TCHF I, Visalakshi has been responsible for creating an ecosystem of active operating advisors and has driven value-add initiatives for TCHF I’s portfolio companies.